Press Releases

Wednesday, March 12, 2025

Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease


Upcoming Events

There are no previous events.


Past Events

2024 ASH Annual Meeting - San Diego Convention Center (RM 31) Oral Presentation - A Novel Direct Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease – In Vivo Efficacy of ILX002 in Humanized Mice
Saturday, December 7, 2024 - 3:00 PM PST

ASH Presentation